Treatment of opioid use disorder with ibogaine: detoxification and drug use outcomes
Brown, T. K., & Alper, K. | The American Journal of Drug and Alcohol Abuse | 25 May 2017
Detoxification from methadone using low, repeated, and increasing doses of ibogaine: A case report
Wilkins, C., dos Santos, R. G., Solá, J., Aixalá, M., Cura, P., Moreno, E., ... & Bouso, J. C. | Journal of Psychedelic Studies | 28 April 2017
Examination of the Phenomenology of the Ibogaine Treatment Experience: Role of Altered States of Consciousness and Psychedelic Experiences
Heink, A., Katsikas, S., & Lange-Altman, T. | Journal of Psychoactive Drugs | 7 March 2017
The Iboga Alkaloids
Lavaud, C., & Massiot, G. | Progress in the Chemistry of Organic Natural Products | 1 January 2017
Treating drug dependence with the aid of ibogaine: A qualitative study
Schenberg, E. E., de Castro Comis, M. A., Alexandre, J. F. M., Chaves, B. D. R., Tófoli, L. F., & da Silveira, D. X. | Journal of Psychedelic Studies | 1 January 2017
The antiaddictive effects of ibogaine: A systematic literature review of human studies
dos Santos, R. G., Bouso, J. C., & Hallak, J. E. | Journal of Psychedelic Studies | 20 December 2016
A One-Dose Psychedelic Fix for Addiction?
Jacobson, R. | Scientific American Mind | 8 December 2016
Tripping up addiction: the use of psychedelic drugs in the treatment of problematic drug and alcohol use
Morgan, C., McAndrew, A., Stevens, T., Nutt, D., & Lawn, W. | Current Opinion in Behavioral Sciences | 15 November 2016
The Resurrection Of Psychedelic Psychiatry And Its Role In Addiction Treatment
Skocylas, R. | UBC Medical Journal | 1 September 2016
Clinical Applications of Hallucinogens: A Review
Garcia-Romeu, A., Kersgaard, B., & Addy, P. H. | Experimental and clinical psychopharmacology | 1 July 2016
Ibogaine and addiction in the animal model, a systematic review and meta-analysis
Belgers, M., Leenaars, M., Homberg, J. R., Ritskes-Hoitinga, M., Schellekens, A. F. A., & Hooijmans, C. R. | Translational psychiatry | 31 May 2016
In reply – on the toxicity of ibogaine
Brunt, T. M., & Litjens, R. P. | Clinical toxicology | 31 May 2016
On the toxicity of ibogaine
Yip, L., & Deng, J. F. | Clinical Toxicology | 31 May 2016
Remission of Severe Opioid Use Disorder with Ibogaine: A Case Report
Cloutier-Gill, L., Wood, E., Millar, T., Ferris, C., & Eugenia Socias, M. | Journal of Psychoactive Drugs | 18 May 2016
Treatment of heroin dependence with ibogaine
Schellekens, A., Oosteren, T., Knuijver, T., & Belgers, M. | European Psychiatry | 12 May 2016
Effects of low dose ibogaine on subjective mood state and psychological performance
Forsyth, B., Machado, L., Jowett, T., Jakobi, H., Garbe, K., Winter, H., & Glue, P. | Journal of Ethnopharmacology | 11 May 2016
Oral noribogaine shows high brain uptake and anti-withdrawal effects not associated with place preference in rodents
Mash, D. C., Ameer, B., Prou, D., Howes, J. F., & Maillet, E. L. | Journal of psychopharmacology (Oxford, England) | 4 April 2016
Anti-addiction Drug Ibogaine Prolongs the Action Potential in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Rubi, L., Eckert, D., Boehm, S., Hilber, K., & Koenig, X. | Cardiovascular Toxicology | 28 March 2016
Ascending single-dose, double-blind, placebo-controlled safety study of noribogaine in opioid-dependent patients
Glue, P., Cape, G., Tunnicliff, D., Lockhart, M., Lam, F., Hung, N., ... & Howes, J. | Clinical Pharmacology in Drug Development | 10 February 2016
How toxic is ibogaine?
Litjens, R. P., & Brunt, T. M. | Clinical Toxicology | 25 January 2016
“Herbal seizures” – atypical symptoms after ibogaine intoxication: a case report
Breuer, L., Kasper, B. S., Schwarze, B., Gschossmann, J. M., Kornhuber, J., & Müller, H. H. | Journal of medical case reports | 31 October 2015
[Psychedelics and quasi-psychedelics in the light of contemporary research: medical cannabis, MDMA, salvinorin A, ibogaine and ayahuasca]
Szabo, A., Kazai, A., Frecska, E., & Brys, Z. | official journal of the Hungarian Association of Psychopharmacology | 17 September 2015
Noribogaine is a G-Protein Biased κ-Opioid Receptor Agonist
Maillet, E. L., Milon, N., Heghinian, M. D., Fishback, J., Schürer, S. C., Garamszegi, N., & Mash, D. C. | Neuropharmacology | 21 Aug 2015
Noribogaine reduces nicotine self-administration in rats
Chang, Q., Hanania, T., Mash, D. C., & Maillet, E. L. | Journal of Psychopharmacology | 20 May 2015
Ibogan, Tacaman, and Cytotoxic Bisindole Alkaloids from Tabernaemontana. Cononusine, an Iboga Alkaloid with Unusual Incorporation of a Pyrrolidone Moiety
Lim, K. H., Raja, V. J., Bradshaw, T. D., Lim, S. H., Low, Y. Y., & Kam, T. S. | Journal of natural products | 28 April 2015